Calidi Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.65	0.64	1.95	0.37	1.06
Cash & Short-Term Investments	0.65	0.64	1.95	0.37	1.06
Cash Growth	-65.58%	-67.37%	423.93%	-64.99%	-
Other Current Assets	10.38	9.59	2.35	0.41	0.42
Total Current Assets	11.03	10.23	4.3	0.79	1.48
Net Property, Plant & Equipment	2.86	3.8	5.34	1.09	-
Long-Term Investments	-	-	-	-	230
Other Long-Term Assets	0.14	0.15	0.37	0.73	0.28
Total Assets	14.03	14.18	10.02	2.6	231.77
Accounts Payable	1.14	2.07	2.88	2.27	0.06
Accrued Expenses	2.17	2.34	5.43	5.35	0.35
Short-Term Debt	-	-	-	1	-
Current Portion of Long-Term Debt	0.41	3.85	0.81	3.27	-
Current Portion of Leases	1.47	1.4	1.12	0.12	-
Other Current Liabilities	-	0.64	-	30.98	-
Total Current Liabilities	5.19	9.5	10.23	42.99	0.41
Long-Term Debt	0.6	0.6	2.06	-	-
Long-Term Leases	0.84	1.95	3.25	0.45	-
Other Long-Term Liabilities	0.2	0.13	2.71	-	16.04
Total Long-Term Liabilities	1.64	2.67	8.02	0.45	16.04
Total Liabilities	6.83	12.21	18.25	43.44	16.45
Common Stock	0	0	0	0	0
Additional Paid-in Capital	144.5	123.28	91.38	19.93	-
Accumulated Other Comprehensive Income	-0.01	-0.03	-0.05	-0.01	-
Retained Earnings	-137.57	-121.72	-99.57	-70.36	-14.69
Total Common Shareholders' Equity	6.92	1.54	-8.24	-50.44	-14.69
Minority Interest	0.28	0.43	-	9.6	230
Shareholders' Equity	7.2	1.97	-8.24	-40.84	215.32
Total Liabilities & Equity	14.03	14.18	10.02	2.6	231.77
Total Debt	3.31	7.79	7.24	4.84	0
Net Cash (Debt)	-2.66	-7.16	-5.29	-4.46	1.06
Net Cash Per Share	-0.94	-10.73	-37.50	-63.02	6.46
Book Value	6.92	1.54	-8.24	-50.44	-14.69
Book Value Per Share	2.45	2.30	-58.40	-712.09	-89.25
Tangible Book Value	6.92	1.54	-8.24	-50.44	-14.69
Tangible Book Value Per Share	2.45	2.30	-58.40	-712.09	-89.25

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q